Davide Baldaccini
Overview
Explore the profile of Davide Baldaccini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sama L, Rodda G, Ruspi L, Sicoli F, DAmato V, Renne S, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272823
Mesenchymal tumors originate from mesenchymal cells and can be either benign or malignant, such as bone, soft tissue, and visceral sarcomas. Surgery is a cornerstone treatment in the management of...
2.
Muraglia L, Lopci E, Jandric J, Zanca R, Rodari M, Perrino M, et al.
Q J Nucl Med Mol Imaging
. 2024 Jun;
68(2):95-100.
PMID: 38860273
Introduction: The aim of this article was to offer a comprehensive non-systematic review of the literature about the use of Nuclear Medicine imaging exams for the evaluation of prostate cancer...
3.
DAgostino G, Badalamenti M, Stefanini S, Baldaccini D, Franzese C, Lo Faro L, et al.
Prostate
. 2023 Dec;
84(4):368-375.
PMID: 38112222
Background: In 2016 we published a phase II study exploring safety and efficacy of Stereotactic Body Radiation Therapy (SBRT) delivered with Volumetric Modulated Arc Therapy (VMAT) and Flattening Filter Free...
4.
Ferrario F, Franzese C, Faccenda V, Vukcaj S, Belmonte M, Lucchini R, et al.
Clin Transl Radiat Oncol
. 2023 Dec;
44:100704.
PMID: 38111610
Background: While SBRT to the prostate has become a valuable option as a radical treatment, limited data support its use in the postoperative setting. Here, we report the updated results...
5.
Francolini G, Banini M, Di Cataldo V, Detti B, Caini S, Loi M, et al.
Prostate
. 2023 Jun;
83(12):1201-1206.
PMID: 37290915
Background: Ultrasensitive imaging has been demonstrated to influence biochemical relapse treatment. PSICHE is a multicentric prospective study, aimed at exploring detection rate with 68Ga-PSMA-11 positron emission tomography/computed tomography (PET/CT) and...
6.
Francolini G, Ganovelli M, Di Cataldo V, Detti B, Caini S, Loi M, et al.
Clin Exp Metastasis
. 2023 Apr;
40(2):197-201.
PMID: 37012498
PSICHE (NCT05022914) is a prospective trial to test a [Ga]Ga- PSMA-11 PET/CT imaging tailored strategy. All evaluable patients had biochemical relapse after surgery and underwent centralized [Ga]Ga-PSMA-11 PET/CT imaging. The...
7.
Lucchini R, Franzese C, Vukcaj S, Purrello G, Panizza D, Faccenda V, et al.
Curr Oncol
. 2022 Dec;
29(12):9349-9356.
PMID: 36547147
Background: The aim of this study was to investigate the feasibility of ultrahypofractionated radiotherapy to the prostate bed in patients with biochemical and/or clinical relapse following radical prostatectomy who were...
8.
Franzese C, Marini B, Baldaccini D, Badalamenti M, Navarria P, Bellu L, et al.
J Cancer Res Clin Oncol
. 2022 Sep;
149(8):4411-4417.
PMID: 36109401
Background: Renal cell carcinoma (RCC) represents 80-90% of all kidney tumors and about 15-25% of patients will develop distant metastases. Systemic therapy represents the standard of care for metastatic patients,...
9.
Navarria P, Baldaccini D, Clerici E, Marini B, Cozzi L, Franceschini D, et al.
Int J Radiat Oncol Biol Phys
. 2022 Aug;
114(4):762-770.
PMID: 35987453
Purpose: The lung is the most frequent site of metastasis in patients with sarcoma. Pulmonary metastasectomy is the most common treatment performed. Stereotactic body radiation therapy (SBRT) has proven to...
10.
Massaro M, Franceschini D, Spoto R, Dominici L, Franzese C, Baldaccini D, et al.
Curr Oncol
. 2022 Jul;
29(7):4893-4901.
PMID: 35877248
Background: This study evaluated the outcome, toxicity and predictive factors in patients unfit for concurrent chemo-radiotherapy (CT-RT) treated with hypofractionated sequential CT-RT or exclusive radiotherapy (RT) for locally advanced non-small...